Ambis# 1686218 rapad recombination

Ended Purchase Order Awarded

Contract number
HHSN272201401091P
Awardee
Awarding agency
Obligated
$5,945

Award facts

Contract value 100% obligated
$5,945.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award, identified as HHSN272201401091P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Viraquest, Inc. for an AMBIS# 1686218 RAPAD RECOMBINATION project. The contract, with a ceiling value of $5,945, is a Firm Fixed Price Purchase Order with an ultimate completion date of October 11, 2014. The contract has no set-aside designation. Viraquest, Inc. is the prime contractor for this award, which is not associated with a larger contract vehicle. The contract is for civilian agency work.

Quick answers

Who was awarded contract HHSN272201401091P?

HHSN272201401091P was awarded to Viraquest, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on September 11, 2014.

How much is contract HHSN272201401091P worth?

The government has obligated $5,945 on HHSN272201401091P.

Was contract HHSN272201401091P competed?

The extent of competition for HHSN272201401091P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award